1. Pharmacy drug adherence: Value
Based Patient Treatment
Adherence: Healthcare Provider and
Patients both are actively engaged in
choosing drug regimen that works.
Value Based Treatment: Patient treatment
that controls the disease progression and
adds to the quality of life based on
medication compliance.

2. Problem Statement
•Drug Discovery cost 2 billion $ per venture or more than $ 1 million /day.
•Patient behaviors include forgetting doses of medication, taking an incorrect dose,
stopping treatment sooner than prescribed, and taking the medication at an incorrect
time, not refilling drugs etc, costing Pharma Industry >500 Billion $ per year.
•Drug prices are increased to offset the lost opportunity but that also intensifies
competition from generic drugs; grown from 18.6 percent in 1984 to 74.5 percent in
2009 for patient treatment.
•Cost to society is $290 Billion/year that includes 100 billion $ avoidable hospital
readmissions alone (2010), a roadblock on controlling rising cost of healthcare.
•In a EMB research (2011), Navin Sinha found only 63% compliance to life threatening
diseases; low adherence results into taking several expensive medicines for multiple
chronic diseases in future which further lowers compliance while increasing cost to
society and healthcare system.
•Incomplete and wrong analytics solutions marketed; measures likelihood to purchase
drugs. Assumes drug purchase leads to further compliance and adherence, and good
patient treatment quality (healthcare outcome). Employers relying on such analytics
will find high employee absenteeism.

3. Solution: Analytics
•Segmentation of patient population for drug non adherence
behavior.
•Retrospective Disease Progression Profiling in each segments.
•Alerts from Predictive Analytics for non compliance in
segments to pharmacists.
•Predict future disease stages or negative healthcare outcome
and associated costs due to non-adherence in all segments to
pharmacists and hospital discharge nurses for communication
with patients.
•Patients sign up for direct delivery of e-alerts and mobile health
for two way participation into better outcome from multiple
stakeholders.

4. Benefits
•Patient Behavioral Modification: solution helps patient
understand the expensive and painful health outcome in future
due to non-adherences; leading to higher compliance.
•Healthcare economy is growing from 2.8 trillion $ in 2010 to
4.6 Trillion $ in 2014; safe and effective use of medications by
patients help save $290 billion $ / year.
•Pharma industry recoups >500 Billion $/ year; can keep
investing heavily in drug discovery to life threatening illnesses.
•Solution helps providers for patient treatment quality and
policy improvements towards stopping 130,000 untimely
deaths/ year from pharmacy drug non-adherence .
•Solution identifies pharmacists and hospital nurses as active
stakeholders towards meeting the goals of Affordable
Healthcare Act of 2009-10; patients are likely to be “active
participants” from multiple points of communication than not.